Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meenakshi Kashyap

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The National Medical Journal of India|May 26, 2011
Liberation treatment for multiple sclerosisMeenakshi Kashyap
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2011
A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancerPeter M Ellis, Normand Blais, Dennis Soulieres, et al.
The Journal of Clinical Investigation|August 11, 2010
Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in miceSam D Molyneux, Marco A Di Grappa, Alexander G Beristain, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The National Medical Journal of India|May 26, 2011
Liberation treatment for multiple sclerosisMeenakshi Kashyap
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2011
A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancerPeter M Ellis, Normand Blais, Dennis Soulieres, et al.
The Journal of Clinical Investigation|August 11, 2010
Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in miceSam D Molyneux, Marco A Di Grappa, Alexander G Beristain, et al.
Pageof 1